Biosimilars
Description: 14F7 is a monoclonal antibody biosimilar expressed in CHO cells, targeting ganglioside N-glycolyl GM..
US$464.00
(100 µg)
Buy it NOW
Description: This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or..
US$435.00
(100 µg)
Buy it NOW
Description: ABX-IL8 is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL8, for use in labora..
US$493.00
(100 µg)
Buy it NOW
Description: Abagovomab is a monoclonal antibody biosimilar expressed in CHO cells, targeting OC126, for use in l..
US$464.00
(100 µg)
Buy it NOW
Description: Abciximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGA2B/ITGB3, for us..
US$493.00
(100 µg)
Buy it NOW
Description: Abelacimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting F11, for use in lab..
US$478.50
(100 µg)
Buy it NOW
Description: Abituzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGAV/CD51, for use..
US$464.00
(100 µg)
Buy it NOW
Description: Abrezekimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL13, for use in l..
US$435.00
(100 µg)
Buy it NOW
Description: Abrilumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGA4/ITGB7, for use..
US$464.00
(100 µg)
Buy it NOW
Description: Acapatamab is a chimeric humanized monoclonal antibody biosimilar expressed in CHO cells, targeting ..
US$449.50
(100 µg)
Buy it NOW
Description: Acasunlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD274/TNFRSF9, for..
US$449.50
(100 µg)
Buy it NOW
Description: This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or..
US$435.00
(100 µg)
Buy it NOW
Description: Actoxumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Clostridium difficil..
US$464.00
(100 µg)
Buy it NOW
Description: Adalimumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFSF2/TNF-alpha/TN..
US$493.00
(100 µg)
Buy it NOW
Description: This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or..
US$435.00
(100 µg)
Buy it NOW
Description: Adecatumumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting EPCAM, for use in..
US$493.00
(100 µg)
Buy it NOW
Description: This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or..
US$435.00
(100 µg)
Buy it NOW
Description: Aducanumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta, for use ..
US$464.00
(100 µg)
Buy it NOW
Description: Afasevikumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL17A/IL17F, for ..
US$478.50
(100 µg)
Buy it NOW
Description: This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or..
US$435.00
(100 µg)
Buy it NOW
Description: Aflibercept is a recombinant fusion protein biosimilar expressed in CHO cells, targeting VEGFA, for ..
US$449.50
(100 µg)
Buy it NOW
Description: Al-901 is a monoclonal antibody biosimilar expressed in CHO cells, targeting IGHE, for use in labora..
US$493.00
(100 µg)
Buy it NOW
Description: Alacizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting KDR/VEGFR2/CD309, f..
US$464.00
(100 µg)
Buy it NOW
Description: Alemtuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD52, for use in l..
US$464.00
(100 µg)
Buy it NOW
Description: Alg-991 is a monoclonal antibody biosimilar expressed in CHO cells, targeting Toxicodendron Urushiol..
US$493.00
(100 µg)
Buy it NOW
Description: Alirocumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PCSK9, for use in l..
US$464.00
(100 µg)
Buy it NOW
Description: Alnuctamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF17/CD3E, for ..
US$449.50
(100 µg)
Buy it NOW
Description: Alomfilimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ICOS, for use in l..
US$449.50
(100 µg)
Buy it NOW